Growth Hormone Secretagogues: A Comprehensive Research Overview
Explore the complete landscape of growth hormone secretagogues including GHRP-2, GHRP-6, Ipamorelin, Hexarelin, MK-677, and GHRH analogs. Understand their mechanisms, compare their profiles, and learn how they differ from exogenous HGH.

Growth hormone (GH) plays a crucial role in metabolism, body composition, tissue repair, and overall health. As natural GH production declines with age, research has focused on ways to restore youthful GH levels. Growth hormone secretagogues (GHS) represent a class of compounds that stimulate the body's own GH production rather than introducing external hormone.
This comprehensive overview covers the major classes of GH secretagogues, their mechanisms, individual compound profiles, and how they compare to direct GH administration.
🔑 Key Takeaways
- GH secretagogues stimulate natural GH release rather than replacing it with exogenous hormone
- Two main pathways exist: GHRH receptor activation and ghrelin/GHS receptor activation
- Different secretagogues have distinct side effect profiles—selectivity matters
- Combining GHRH analogs with GHRPs produces synergistic effects
- MK-677 (Ibutamoren) is unique as an orally-active, non-peptide secretagogue
How Growth Hormone Release Works
Growth hormone release from the pituitary gland is controlled by a delicate balance of stimulating and inhibiting signals:
Stimulating Signals
GHRH (Growth Hormone Releasing Hormone) from the hypothalamus tells the pituitary to produce and release GH. Ghrelin from the stomach also powerfully stimulates GH release.
Inhibiting Signals
Somatostatin (GHIH) inhibits GH release. IGF-1 provides negative feedback, reducing GH when levels are sufficient.
GH is released in pulses throughout the day, with the largest pulse occurring during deep sleep. This pulsatile pattern is important—continuous GH elevation doesn't produce the same benefits as natural pulsatile release.
Two Pathways to Stimulate GH
Growth hormone secretagogues work through two main mechanisms:
| Pathway | Receptor | Compounds | Effect |
|---|---|---|---|
| GHRH Pathway | GHRH Receptor | Sermorelin, CJC-1295, Tesamorelin | Increases GH synthesis and primes cells for release |
| Ghrelin Pathway | GHS-R1a (Ghrelin Receptor) | GHRP-2, GHRP-6, Ipamorelin, Hexarelin, MK-677 | Amplifies GH release, reduces somatostatin inhibition |
Explore Premium Research Peptides
Discover high-quality peptides from our trusted research partner.
Apollo PeptidesGHRH Analogs: The Stimulators
These peptides mimic the body's natural GHRH, signaling the pituitary to produce and release growth hormone.
Sermorelin
Sermorelin is a 29-amino acid peptide representing the bioactive portion of natural GHRH (which has 44 amino acids).
Sermorelin Profile
- Half-life: 10-20 minutes
- Dosing: Typically 200-300mcg before bed
- Advantages: Well-studied, FDA history (Geref), natural mechanism
- Disadvantages: Short half-life requires precise timing, modest GH increase alone
- Best for: Foundational GH support, sleep quality, combining with GHRPs
CJC-1295 (with and without DAC)
CJC-1295 is a modified GHRH analog with enhanced stability. It comes in two forms:
| Form | Half-Life | Dosing Frequency | GH Pattern |
|---|---|---|---|
| CJC-1295 no DAC (Mod GRF 1-29) | ~30 minutes | 1-3x daily | Pulsatile (more natural) |
| CJC-1295 with DAC | 6-8 days | 1-2x weekly | Sustained elevation ("GH bleed") |
Tesamorelin
Tesamorelin is FDA-approved (Egrifta) for HIV-associated lipodystrophy. It's a stabilized GHRH analog.
Tesamorelin Profile
- Half-life: 26-38 minutes
- FDA Status: Approved for HIV lipodystrophy
- Dosing: 2mg daily (approved dose)
- Notable: Strong evidence for visceral fat reduction
- Cost: Expensive as a pharmaceutical product
Growth Hormone Releasing Peptides
GHRPs mimic ghrelin, activating the GHS-R1a receptor to amplify GH release. Each has a distinct profile of effects beyond GH stimulation.
GHRP-6
GHRP-6 was one of the first GHRPs developed and remains widely used.
GHRP-6 Profile
- GH Release: Strong
- Hunger Effect: Significant - notably increases appetite
- Cortisol: Moderate increase
- Prolactin: Slight increase
- Dosing: 100-300mcg, 2-3x daily
- Best for: Those wanting appetite stimulation, bulking phases
- Avoid if: Appetite increase is undesirable
GHRP-2
GHRP-2 is considered the most potent GHRP for pure GH release.
GHRP-2 Profile
- GH Release: Strongest among GHRPs
- Hunger Effect: Moderate (less than GHRP-6)
- Cortisol: Notable increase
- Prolactin: Notable increase
- Dosing: 100-300mcg, 2-3x daily
- Best for: Maximum GH release when cortisol/prolactin aren't concerns
- Avoid if: Sensitive to cortisol or prolactin effects
Ipamorelin
Ipamorelin is often called the "cleanest" GHRP due to its selectivity.
Ipamorelin Profile
- GH Release: Good (not strongest, but consistent)
- Hunger Effect: Minimal
- Cortisol: Minimal increase
- Prolactin: Minimal increase
- Dosing: 100-300mcg, 2-3x daily
- Best for: Clean GH release without unwanted side effects
- Most popular: Due to excellent side effect profile
Hexarelin
Hexarelin is one of the strongest GHRPs but comes with more side effects.
Hexarelin Profile
- GH Release: Very strong (similar to GHRP-2)
- Hunger Effect: Moderate
- Cortisol: Significant increase
- Prolactin: Significant increase
- Notable: Cardioprotective effects observed in research
- Desensitization: Higher tendency for receptor desensitization
- Dosing: 100-200mcg, 2-3x daily (lower due to potency)
GHRP Comparison Summary
| Peptide | GH Release | Hunger | Cortisol | Prolactin | Best For |
|---|---|---|---|---|---|
| Ipamorelin | +++ | + | + | + | General use, clean profile |
| GHRP-2 | +++++ | ++ | +++ | +++ | Maximum GH release |
| GHRP-6 | ++++ | +++++ | ++ | ++ | Appetite stimulation, bulking |
| Hexarelin | +++++ | ++ | ++++ | ++++ | Short-term potent use, cardiac research |
MK-677 (Ibutamoren): The Oral Secretagogue
MK-677 (Ibutamoren) deserves special attention as the only orally-active GH secretagogue in common use. Technically not a peptide, it's a non-peptide ghrelin mimetic.
MK-677 Profile
- Administration: Oral (unique among secretagogues)
- Half-life: 24+ hours
- GH Release: Sustained elevation throughout the day
- IGF-1 Increase: Significant and sustained
- Hunger Effect: Notable, especially initially
- Water Retention: More common than with peptide GHRPs
- Dosing: 10-25mg once daily
MK-677 Considerations
| Pros | Cons |
|---|---|
| Oral administration (no injections) | 24/7 GH elevation (not pulsatile) |
| Once-daily dosing | Increased hunger and appetite |
| Sustained IGF-1 elevation | Water retention common |
| Well-studied in clinical trials | May affect blood glucose/insulin |
| Doesn't require reconstitution | Not suitable for everyone |
Secretagogues vs. Exogenous HGH
How do secretagogues compare to direct growth hormone administration?
| Factor | GH Secretagogues | Exogenous HGH |
|---|---|---|
| Mechanism | Stimulates natural production | Directly introduces external GH |
| Release Pattern | Can maintain pulsatile release | Non-pulsatile (depends on dosing) |
| Natural Production | Preserved or enhanced | Suppressed over time |
| IGF-1 Levels | Moderate increase | High, dose-dependent |
| Cost | Generally lower | High (pharmaceutical grade) |
| Legal Status | Research chemicals (mostly) | Prescription only, controlled |
| Side Effects | Generally milder | More significant at higher doses |
| Efficacy | More modest | More dramatic effects |
When Secretagogues May Be Preferred
- Maintaining natural GH production and feedback systems
- Milder, more gradual effects desired
- Cost considerations
- Preference for natural pulsatile release
- Long-term protocols where suppression is a concern
When HGH May Be Preferred
- Clinically diagnosed GH deficiency
- Maximum GH/IGF-1 levels needed
- Pituitary function is compromised
- Medical supervision and prescription available
Combining Secretagogues: Synergy
Explore Premium Research Peptides
Discover high-quality peptides from our trusted research partner.
Apollo PeptidesAs discussed in our CJC-1295 + Ipamorelin guide, combining GHRH analogs with GHRPs produces synergistic effects:
Common Combinations
- CJC-1295 (no DAC) + Ipamorelin: Most popular, clean profile
- Sermorelin + GHRP-2: Maximum GH stimulation
- Sermorelin + GHRP-6: With appetite stimulation
- Tesamorelin + Ipamorelin: Pharmaceutical GHRH + clean GHRP
Synergy occurs because you're activating both GH-releasing pathways simultaneously. Research shows combined use can produce GH peaks 3-10x higher than either compound alone.
General Dosing Principles
Timing Considerations
Fasted State
GH secretagogues work best on an empty stomach. Carbohydrates and fats raise insulin, which blunts GH release. Fast for 2-3 hours before dosing.
Before Sleep
The pre-sleep dose is often considered most important as it amplifies the natural nocturnal GH surge during deep sleep.
Post-Workout
GH sensitivity is elevated after exercise. A post-workout dose can enhance recovery.
Morning (Optional)
A morning fasted dose provides GH support during waking hours. Wait 20-30 minutes before eating.
Sample Protocols
| Goal | Protocol | Timing |
|---|---|---|
| Sleep/Recovery Focus | Ipamorelin 200mcg + CJC-1295 100mcg | Pre-sleep only |
| Moderate Enhancement | Ipamorelin 200mcg + CJC-1295 100mcg | 2x daily (morning + pre-sleep) |
| Maximum Stimulation | GHRP-2 200mcg + CJC-1295 100mcg | 3x daily (fasted, post-workout, pre-sleep) |
| Oral Convenience | MK-677 15-25mg | Once daily (evening often preferred) |
Side Effects Management
Water Retention
Common with GH secretagogues, especially MK-677:
- Usually subsides after 2-3 weeks
- Manage sodium intake
- Stay well-hydrated
- Consider lower doses initially
Hunger Increase
Particularly with GHRP-6 and MK-677:
- Time doses strategically (before planned meals)
- Use Ipamorelin if hunger is problematic
- Often diminishes over time
Lethargy/Fatigue
Sometimes reported initially:
- Usually temporary (first 1-2 weeks)
- Evening dosing can leverage this for sleep
- May indicate dose is too high
Frequently Asked Questions
Conclusion
Growth hormone secretagogues offer a way to enhance natural GH production without the suppression and risks associated with exogenous HGH. From the clean profile of Ipamorelin to the potent GH release of GHRP-2, from the convenient oral dosing of MK-677 to the synergistic combinations of GHRH analogs with GHRPs, there are options suited to various research goals.
The key is understanding each compound's unique profile—not just GH release potency, but effects on hunger, cortisol, prolactin, and other factors. Selecting the right secretagogue (or combination) depends on individual goals, tolerance for side effects, and practical considerations like dosing frequency.
Explore individual compound profiles for more detail: Ipamorelin, CJC-1295, GHRP-2, GHRP-6, MK-677, Sermorelin, Hexarelin, Tesamorelin.
Explore Premium Research Peptides
Discover high-quality peptides from our trusted research partner.
Apollo Peptides

